Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cecka

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Clinical Transplants|January 1, 1996
Risk rate and long-term kidney transplant survivalP I Terasaki, J M Cecka, D W Gjertson, et al.
Immunobiology|December 1, 1984
Heterogeneity of accessory cellsP Erb, G Ramila, S Studer, et al.
Transplantation|August 1, 1991
HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplantsY Kato, Y Mitsuishi, M Cecka, et al.
Clinical Transplants|January 1, 1994
UCLA liver transplantation: analysis of the first 1,000 patientsS Dawson, D K Imagawa, J M Cecka, et al.
Artificial Organs|October 1, 1996
UCLA liver transplantation: analysis of immunological factors affecting outcomeS Dawson, D K Imagawa, C Johnson, et al.
Clinical Transplants|January 1, 1995
How should cadaver-donor kidneys be allocated in the United States?J S Wolf, C O Callender, P I Terasaki, et al.
Clinical Transplants|January 1, 1995
Advances in kidney transplantation: 1985-1995P I Terasaki, J D McClelland, J Yuge, et al.
Clinical Transplants|January 1, 1992
Kidney allocation under the UNOS point system: an updateJ McClelland, K Steidler, J M Cecka, et al.
Clinical Transplants|January 1, 1988
Clinical transplants 1988. OverviewP I Terasaki, J M Cecka, S Takemoto, et al.
Clinical Transplants|January 1, 1991
UCLA and UNOS Registries. OverviewP I Terasaki, J M Cecka, E Lim, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Clinical Transplants|January 1, 1996
Risk rate and long-term kidney transplant survivalP I Terasaki, J M Cecka, D W Gjertson, et al.
Immunobiology|December 1, 1984
Heterogeneity of accessory cellsP Erb, G Ramila, S Studer, et al.
Transplantation|August 1, 1991
HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplantsY Kato, Y Mitsuishi, M Cecka, et al.
Clinical Transplants|January 1, 1994
UCLA liver transplantation: analysis of the first 1,000 patientsS Dawson, D K Imagawa, J M Cecka, et al.
Artificial Organs|October 1, 1996
UCLA liver transplantation: analysis of immunological factors affecting outcomeS Dawson, D K Imagawa, C Johnson, et al.
Clinical Transplants|January 1, 1995
How should cadaver-donor kidneys be allocated in the United States?J S Wolf, C O Callender, P I Terasaki, et al.
Clinical Transplants|January 1, 1995
Advances in kidney transplantation: 1985-1995P I Terasaki, J D McClelland, J Yuge, et al.
Clinical Transplants|January 1, 1992
Kidney allocation under the UNOS point system: an updateJ McClelland, K Steidler, J M Cecka, et al.
Clinical Transplants|January 1, 1988
Clinical transplants 1988. OverviewP I Terasaki, J M Cecka, S Takemoto, et al.
Clinical Transplants|January 1, 1991
UCLA and UNOS Registries. OverviewP I Terasaki, J M Cecka, E Lim, et al.
Pageof 20